GLP1R and type 2 diabetes mellitus: Metformin-treated patients with type 2 diabetes exhibited elevated plasma GLP-1 levels and reduced glucose absorption from the gut lumen during a duodenal glucose infusion, with a significant correlation between the GLP-1 increment and the impairment of luminal glucose uptake [46].